封面
市場調查報告書
商品編碼
1969992

全球空間體學市場規模、佔有率、趨勢和成長分析報告(2026-2034)

Global Spatial Omics Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計空間體學市場將從 2025 年的 8.4 億美元成長到 2034 年的 34.1 億美元,2026 年至 2034 年的複合年成長率為 16.81%。

受基因組學和精準醫學發展趨勢的推動,全球空間體學市場正經歷快速成長。空間體學技術使研究人員能夠在組織的空間背景下研究基因和蛋白質的表達。這種方法能夠深入了解疾病機制,尤其是在癌症研究和神經科學領域。生命科學研究經費的增加和對個人化醫療日益成長的需求是推動市場擴張的關鍵因素。

製藥和生物技術公司正在採用空間體學技術來改善藥物發現和開發流程。學術研究機構也大力投資先進的成像技術和定序技術。慢性病發病率的上升以及對精準診斷日益成長的需求進一步推動了這一趨勢。成像平台和生物資訊學工具的技術進步正在提高數據準確性和研究效率。

未來幾年,隨著技術的普及和成本效益的提高,市場預計將顯著成長。研究機構與產業界的合作將促進創新,新興醫療市場的擴張以及政府對基因組研究支持的加強將創造新的機會。隨著精準醫療的普及,空間體學將在變革全球醫療保健解決方案方面發揮關鍵作用。

目錄

第1章:引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章:全球空間體學市場:依技術分類

  • 市場分析、洞察與預測
  • 空間轉錄組學
  • 空間基因體學
  • 空間蛋白質體學

第5章:全球空間體學市場:依產品分類

  • 市場分析、洞察與預測
  • 裝置
  • 消耗品
  • 軟體

第6章:全球空間體學市場:依工作流程分類

  • 市場分析、洞察與預測
  • 樣品製備
  • 儀器分析
  • 數據分析

第7章:全球空間體學市場:依樣本類型分類

  • 市場分析、洞察與預測
  • FFPE
  • 新鮮和冷凍

第8章:全球空間體學市場:依最終用途分類

  • 市場分析、洞察與預測
  • 學術研究機構與轉化研究機構
  • 製藥和生物技術公司

第9章:全球空間體學市場:按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴(根據現有資訊)
  • 市場佔有率和市場定位分析(基於現有資訊)
  • 供應商情況(基於現有資訊)
  • 策略規劃

第11章:公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • 10x Genomics
    • Bio-Techne
    • Bruker
    • Dovetail Genomics
    • S2 Genomics Inc
    • Akoya Biosciences Inc
    • RareCyte Inc
    • Standard BioTools
    • Rebus Biosystems Inc
    • Vizgen Inc
簡介目錄
Product Code: VMR112110693

The Spatial Omics Market size is expected to reach USD 3.41 Billion in 2034 from USD 0.84 Billion (2025) growing at a CAGR of 16.81% during 2026-2034.

The Global Spatial Omics Market is experiencing rapid growth due to advancements in genomics and precision medicine. Spatial omics technologies allow researchers to study gene and protein expression within the spatial context of tissues. This approach provides deeper insights into disease mechanisms, especially in cancer research and neuroscience. Increasing funding for life sciences research and the rising demand for personalized medicine are major drivers supporting market expansion.

Pharmaceutical and biotechnology companies are adopting spatial omics to improve drug discovery and development processes. Academic research institutions are also investing heavily in advanced imaging and sequencing technologies. The growing prevalence of chronic diseases, along with the need for accurate diagnostics, is further strengthening demand. Technological advancements in imaging platforms and bioinformatics tools are enhancing data accuracy and research efficiency.

In the coming years, the market is expected to grow significantly as technology becomes more accessible and cost-effective. Collaborations between research institutions and industry players will drive innovation. Expansion in emerging healthcare markets and increased government support for genomic research will create new opportunities. As precision medicine becomes more mainstream, spatial omics will play a vital role in transforming healthcare solutions globally.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Technology

  • Spatial Transcriptomics
  • Spatial Genomics
  • Spatial Proteomics

By Product

  • Instruments
  • Consumables
  • Software

By Workflow

  • Sample Preparation
  • Instrumental Analysis
  • Data Analysis

By Sample Type

  • FFPE
  • Fresh Frozen

By End-use

  • Academic & Translational Research Institutes
  • Pharmaceutical & Biotechnology Companies

COMPANIES PROFILED

  • 10x Genomics, BioTechne, Bruker, Dovetail Genomics, S2 Genomics Inc, Akoya Biosciences Inc, RareCyte Inc, Standard BioTools, Rebus Biosystems Inc, Vizgen Inc
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL SPATIAL OMICS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Technology
  • 4.2. Spatial Transcriptomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Spatial Genomics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Spatial Proteomics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL SPATIAL OMICS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Software Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL SPATIAL OMICS MARKET: BY WORKFLOW 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Workflow
  • 6.2. Sample Preparation Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Instrumental Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Data Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL SPATIAL OMICS MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Sample Type
  • 7.2. FFPE Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Fresh Frozen Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL SPATIAL OMICS MARKET: BY END-USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End-use
  • 8.2. Academic & Translational Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL SPATIAL OMICS MARKET: BY REGION 2022-2034(USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Technology
    • 9.2.2 By Product
    • 9.2.3 By Workflow
    • 9.2.4 By Sample Type
    • 9.2.5 By End-use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Technology
    • 9.3.2 By Product
    • 9.3.3 By Workflow
    • 9.3.4 By Sample Type
    • 9.3.5 By End-use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Technology
    • 9.4.2 By Product
    • 9.4.3 By Workflow
    • 9.4.4 By Sample Type
    • 9.4.5 By End-use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Technology
    • 9.5.2 By Product
    • 9.5.3 By Workflow
    • 9.5.4 By Sample Type
    • 9.5.5 By End-use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 South East Asia
    • 9.5.11 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Technology
    • 9.6.2 By Product
    • 9.6.3 By Workflow
    • 9.6.4 By Sample Type
    • 9.6.5 By End-use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL SPATIAL OMICS INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 10x Genomics
    • 11.2.2 Bio-Techne
    • 11.2.3 Bruker
    • 11.2.4 Dovetail Genomics
    • 11.2.5 S2 Genomics Inc
    • 11.2.6 Akoya Biosciences Inc
    • 11.2.7 RareCyte Inc
    • 11.2.8 Standard BioTools
    • 11.2.9 Rebus Biosystems Inc
    • 11.2.10 Vizgen Inc